CO6602140A2 - Proceso para producir un extracto de alergenos - Google Patents

Proceso para producir un extracto de alergenos

Info

Publication number
CO6602140A2
CO6602140A2 CO12155801A CO12155801A CO6602140A2 CO 6602140 A2 CO6602140 A2 CO 6602140A2 CO 12155801 A CO12155801 A CO 12155801A CO 12155801 A CO12155801 A CO 12155801A CO 6602140 A2 CO6602140 A2 CO 6602140A2
Authority
CO
Colombia
Prior art keywords
produce
allergen extract
extracts
relates
allergen extracts
Prior art date
Application number
CO12155801A
Other languages
English (en)
Inventor
Sanchez Jeronimo Carnes
Original Assignee
Leti S L Unipersonal Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti S L Unipersonal Lab filed Critical Leti S L Unipersonal Lab
Publication of CO6602140A2 publication Critical patent/CO6602140A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un proceso para la producción de extractos alérgenos nativos, des pigmentados y polimerizados. Específicamente, el proceso comprende un paso intermedio para la posterior mejora del proceso de polimerización y la reducción de la alergenicidad de los extractos alérgenos. La invención también se refiere a los extractos alérgenos obtenidos mediante el proceso mencionado, composiciones farmacéuticas y vacunas que comprenden los extractos purificados.
CO12155801A 2010-02-12 2012-09-11 Proceso para producir un extracto de alergenos CO6602140A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201030199 2010-02-12

Publications (1)

Publication Number Publication Date
CO6602140A2 true CO6602140A2 (es) 2013-01-18

Family

ID=43760024

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12155801A CO6602140A2 (es) 2010-02-12 2012-09-11 Proceso para producir un extracto de alergenos

Country Status (17)

Country Link
US (3) US9884111B2 (es)
EP (2) EP2533808B1 (es)
JP (3) JP5969922B2 (es)
CN (2) CN102821785B (es)
AU (1) AU2011214316B2 (es)
BR (1) BR112012019848B1 (es)
CA (2) CA3060638A1 (es)
CL (1) CL2012002246A1 (es)
CO (1) CO6602140A2 (es)
EC (1) ECSP12012102A (es)
ES (2) ES2395093T3 (es)
MX (1) MX2012009267A (es)
PE (1) PE20130044A1 (es)
PL (2) PL2853271T3 (es)
PT (2) PT2533808E (es)
RU (2) RU2572230C2 (es)
WO (1) WO2011098569A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395093T3 (es) 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos
LT2875828T (lt) * 2012-07-20 2019-07-25 Diater, Laboratorio de Diagnostico y Aplicaciones TerapĆ©uticas, S.A. Kompozicijos, skirtos polimerintų alergenų intraderminiam įvedimui
CN104447943A (zh) * 2014-11-21 2015-03-25 浙江我武生物科技股份有限公司 一种提取狗毛皮屑变应原的方法
JP7341138B2 (ja) * 2017-07-31 2023-09-08 レティ・ファルマ・ソシエダ・リミタダ 動物用製品
US11408895B1 (en) 2018-04-09 2022-08-09 Hob Biotech Group Corp., Ltd. Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay
AU2019422413A1 (en) * 2019-01-17 2021-08-26 LETI Pharma S.L. Methods of purifying an allergen extract
CN113817037A (zh) * 2021-10-29 2021-12-21 南昌大学 一种从生腰果中制备高纯度致敏原Ana o 3的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463740A (en) 1946-03-29 1949-03-08 Raymond S Burnett Preparation of peanut protein free from peanut skin pigment
GB1283989A (en) * 1969-12-15 1972-08-02 Omega Lab Ltd Allergenic extracts and method for their preparation
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
JPS5645417A (en) * 1979-09-19 1981-04-25 Mochida Pharmaceut Co Ltd Pharmaceutical composition having antiallergic activity
EP0083497A3 (en) * 1982-01-06 1985-11-06 Beecham Group Plc Process for preparing modified allergens, their use in treating allergic conditions
US4716120A (en) * 1983-03-17 1987-12-29 Minnesota Mining And Manufacturing Company Stable allergenic extracts and methods
ES2013359A6 (es) * 1988-11-04 1990-05-01 Corporacion Biolog Farmaceutic Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
WO1992019970A1 (en) 1991-04-26 1992-11-12 Emanuel Calenoff Methods to detect and treat diseases caused by bacterial allergens
AU675629B2 (en) 1992-09-21 1997-02-13 Laboratorios Leti S.A. A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
JP3397791B2 (ja) * 1992-09-21 2003-04-21 ラボラトリオス レティ ソシエダッド アノニマ アレルゲンとして活性なタンパク質を含有する水性エキスの精製方法,この方法で得られるエキスならびにそれらの使用
JP2005503113A (ja) * 2001-02-05 2005-02-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ブタクサアレルゲン
ES2869895T3 (es) * 2001-03-09 2021-10-26 Chugai Pharmaceutical Co Ltd Método de purificación de proteínas
RU2205661C2 (ru) * 2001-07-13 2003-06-10 Петров Рем Викторович Аллерготропин для лечения полинозов и способ лечения полинозов
CN1430052A (zh) * 2001-12-31 2003-07-16 合富生化科技股份有限公司 过敏原检测芯片
FR2841906B1 (fr) * 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
ZA200504990B (en) * 2003-01-09 2006-08-30 Genentech Inc Purification of polypeptides
DE60301944T2 (de) 2003-01-21 2006-06-01 Biomay Produktions- Und Handels-Aktiengesellschaft Verfahren zur Vorbereitung von hypoallergenen Mosaikproteinen#
EP1834649A1 (en) 2006-03-14 2007-09-19 Alk-Abello A/S Method of developing a process for producing an allergen extract
DK1834648T3 (da) * 2006-03-14 2013-11-04 Alk Abello As Fremgangsmåde til fremstilling af et allergenekstrakt
US7887821B2 (en) * 2007-12-20 2011-02-15 Alk-Abello A/S Process for producing an allergen extract
ES2395093T3 (es) * 2010-02-12 2014-12-22 Laboratorios Leti, S.L. Proceso para producir un extracto de alérgenos

Also Published As

Publication number Publication date
US11246923B2 (en) 2022-02-15
BR112012019848A2 (pt) 2020-07-07
ES2676058T3 (es) 2018-07-16
US20150306211A1 (en) 2015-10-29
PL2853271T3 (pl) 2018-09-28
RU2572230C2 (ru) 2015-12-27
EP2533808A1 (en) 2012-12-19
ES2395093T3 (es) 2014-12-22
RU2012134032A (ru) 2014-03-20
JP2013519656A (ja) 2013-05-30
PE20130044A1 (es) 2013-02-14
RU2015149538A3 (es) 2019-05-08
US20180200363A1 (en) 2018-07-19
EP2853271A1 (en) 2015-04-01
ECSP12012102A (es) 2013-04-30
MX2012009267A (es) 2013-02-07
US20180200362A1 (en) 2018-07-19
AU2011214316A1 (en) 2012-08-16
PT2533808E (pt) 2014-11-28
EP2533808B1 (en) 2014-08-20
US9884111B2 (en) 2018-02-06
BR112012019848B1 (pt) 2022-03-15
JP2017226687A (ja) 2017-12-28
RU2706685C2 (ru) 2019-11-20
CN102821785B (zh) 2014-12-10
JP5969922B2 (ja) 2016-08-17
CL2012002246A1 (es) 2013-05-24
JP2016145235A (ja) 2016-08-12
RU2015149538A (ru) 2019-01-15
CN104371016A (zh) 2015-02-25
CN104371016B (zh) 2018-05-15
EP2853271B1 (en) 2018-04-04
WO2011098569A1 (en) 2011-08-18
JP6646480B2 (ja) 2020-02-14
AU2011214316B2 (en) 2015-07-02
ES2395093T1 (es) 2013-02-08
CN102821785A (zh) 2012-12-12
CA2789174C (en) 2021-08-24
CA2789174A1 (en) 2011-08-18
PT2853271T (pt) 2018-07-09
PL2533808T3 (pl) 2015-03-31
WO2011098569A9 (en) 2012-03-15
CA3060638A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
CO6602140A2 (es) Proceso para producir un extracto de alergenos
DOP2021000179A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
CO2020001927A2 (es) Método de producción de composiciones farmacéuticas que comprende el virus chikungunya inmunogénico chikv-delta5nsp3
EA201890883A1 (ru) Вакуумная дистилляция для обогащения каннабидиола
GT201400178A (es) Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks
CR20120215A (es) Anticuerpos contra csf-1r humano y usos de los mismos
CO7081144A2 (es) Anticuerpos biespecíficos contra tweak humana e il17 humana y usos de los mismos
CY1116812T1 (el) Προϊον εκχυλισης ελαιου toy indigo naturalis και η διαδικασια παρασκευης και η χρηση του
BR112015000534A8 (pt) “método para a preparação de 2,4-dihidroxibutirato, microrganismo modificado e método de produção de 2,4-dhb”
GEP201706623B (en) Pyrrolotriazinone derivatives as pi3k inhibitors
MX349119B (es) Vacuna de virus de dengue inactivado.
BR112018011526A2 (pt) compostos policíclicos como inibidores da tirosina quinase de bruton
NI201100163A (es) Un complejo de haluro de hidrógeno de agomelatina y la preparación del mismo
BR112017008656A2 (pt) composição, método de produção da composição, usos da composição, método de preparo de combustível, e combustível
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
BR112016018347A2 (pt) Método para a produção de composições enriquecidas em vitamina e, especialmente enriquecidas em tocotrienol, a partir de óleos naturais
BR112015007843A2 (pt) método para a preparação de um polímero, polímero, artigo e método de preparação de um artigo
BR112015013453A2 (pt) preparação de uma bebida estável
BR112014029075A2 (pt) poliamida de moldagem; método para a preparação de poliamida de moldagem; e uso da poliamida de moldagem
UY35986A (es) Método mejorado para la producción de extractos de ginkgo
MX2017005578A (es) Métodos de administración de composiciones de amantadina.
BR112017013574A2 (pt) conjugados de aminoácido e peptídeo e usos dos mesmos
CL2017000153A1 (es) Composiciones de azúcares para la formación de comprimidos mediante compresión directa
BR112019007073A2 (pt) extrato de planta embebido em alulose e método de preparação
BR112016030728A2 (pt) método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença